Sanjay Subramanian - Mar 21, 2022 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, CFO
Signature
/s/ Sanjay Subramanian
Stock symbol
INZY
Transactions as of
Mar 21, 2022
Transactions value $
$0
Form type
4
Date filed
3/22/2022, 04:11 PM
Previous filing
Jan 5, 2022
Next filing
Apr 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock option (right to buy) Award $0 +180K $0.00 180K Mar 21, 2022 Common Stock 180K $3.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on March 21, 2022 and is scheduled to vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the option are scheduled to vest in equal monthly installments over the following three years until the fourth anniversary of the grant date.